
Azelaprag
CAS No. 2049980-18-7
Azelaprag( —— )
Catalog No. M33277 CAS No. 2049980-18-7
Azelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 602 | In Stock |
![]() ![]() |
5MG | 1121 | In Stock |
![]() ![]() |
10MG | 1454 | In Stock |
![]() ![]() |
25MG | 1987 | In Stock |
![]() ![]() |
50MG | 2576 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAzelaprag
-
NoteResearch use only, not for human use.
-
Brief DescriptionAzelaprag (AMG 986) is an effective small-molecule apelin receptor agonist. Azelaprag can be used to treat neurological diseases and cardiovascular diseases.
-
DescriptionAzelaprag (Example 263.0) is an apelin receptor agonist agent candidate.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorApelin receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2049980-18-7
-
Formula Weight523.61
-
Molecular FormulaC25H29N7O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (9.55 mM; Ultrasonic )
-
SMILESN(S([C@H]([C@H](C)C=1N=CC(C)=CN1)C)(=O)=O)C=2N(C(=NN2)C=3C=C(C)C=NC3)C4=C(OC)C=CC=C4OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WO2016187308A1.
molnova catalog



related products
-
7,12-DIMETHYLBENZ[A]...
7,12-Dimethylbenz[a]anthracene is a highly potent carcinogen that is activated by microsomal enzymes to a diol epoxide metabolite that binds covalently to DNA in mammalian cells, leading ultimately to tumor induction.
-
Gimeracil
An inhibitor of dihydropyrimidine dehydrogenase, degrades pyrimidine including 5-fluorouracil in the blood.
-
BMS-502
BMS-502 is a potent dual inhibitor of diacylglycerol kinase (DGK) α and ζ that induces immune responses in human and mouse T cells and blocks intracellular checkpoint signaling in T cells.